Global RPM INC.

Global RPM INC. was paid $238K by Medicaid between Jan 2021 and Oct 2021, across 11 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 37% of everything it billed.

33Billing provider infoGLOBAL RPM INC.
HUNTINGTON BEACH, CA 92647

33aNPI1952907495assigned 12/09/2020

33bProvider typeInternal Medicine Physician

28Total paid$238K

24GClaims13,253

24DCodes billed11

24AFirst – last monthJan 2021 – Oct 2021

Compared with peers

Next to other Internal Medicine Physician providers in California

Rank by total paid#396 of 2,679

Median peer was paid$13K

This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	13,253	$238K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	37%	2,892	2,009	$87K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	20%	3,606	2,446	$47K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	19%	1,034	923	$46K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	17%	3,554	2,404	$41K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	2.6%	272	266	$6K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.2%	673	603	$5K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	1.6%	142	117	$4K
86328		<1%	36	32	$1K
99072		<1%	822	679	$214.91
99001		<1%	208	194	$163.69
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	14	14	$160.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHILTON, DANIEL (PRESIDENT)